Wednesday, 18 December 2019

Global Wound care Market Opportunities 2019-2027 | MRFR

Wound care Market Scenario:
Wound care products are used for the treatment or closure of wounds. The global wound care market is anticipated to generate at a CAGR of 6.2 % during the review period.
Market Dynamics:
Drivers
The ubiquitous applications of wound care coupled with the rising cases of trauma owing to growth in risk factors such as accidents, industrial hazards, sports culture, etc. are the prime drivers of the market. According to the American Burn Association estimates, approximately 486,000 burn injuries were reported in 2015. Advancements in wound care & closure products is resulting in increased substitution of traditional products owing to their effectiveness and efficacy.
Increased cases of diabetes and growing demand for cosmetic surgeries are other drivers of the market. There has been a strong demand for anti-scar products to treat complex wounds. Advanced materials include hydrogels, alginates, hydrocolloids, etc. which by providing moisture encourages natural cell repair. Hydrocolloid substances such as gelatin and cellulose, are being incorporated in products to absorb fluids, dirt, bacteria, and forming a protective gel mass without sticking to the wound itself.
Restraints
The high cost of advanced wound care products is the prime constraint on the market. Lack of awareness and low per capita income are other restraints on the market.
Wound care Market Segmentation:
To generate an advanced understanding of the global wound care market, the report is segmented on the basis of product, type, application, and end users.
Based on products, the market is segmented by traditional wound care products, advanced wound management products, wound care products, wound therapy devices, active wound care products, and others. The advanced wound management products segment is sub segmented into foam dressings, advanced wound dressings, collagen dressings, alginate dressings, hydrogel dressings, hydrocell foam dressings, others. The wound therapy devices segment is sub segmented into negative pressure wound therapy device (NPWT), electrical stimulation devices, oxygen and hyperbaric oxygen equipment, cutting edge wound therapy device, and others. The wound care products segment is sub segmented into sutures, surgical staples, wound care strips, haemostats, adhesives and tissue sealants, and others. The active wound care products segment is sub segmented into artificial skin and skin substitutes, topical agents, and others.
Based on the type, the market is categorized into chronic wounds, acute wounds, and others.
Based on the application, the market is segmented surgical wounds, ulcers, trauma wounds, burn, and others.
Based on the end users, the market is segmented into hospitals, clinics, trauma centers, home healthcare, and others.
Based on the regions, the market has been segmented by North America, Europe, Asia Pacific, Middle East and Africa.
Regional Analysis:
The Americas led by the U.S. dominate the global wound care market owing to a well-developed healthcare sector and high per capita income. The presence of global players like 3M and Baxter along-with the developed economies like the U.S and Canada within the region fuels the market growth.
Europe accounts for the second largest market for wound care. According to the National Health Service, the cost of caring for patients with chronic wounds in U.K. was estimated to be around USD 3.4 to 4.6 billion per year. Europe is led by Germany, France and the U.K.
Asia Pacific is the fastest growing region for the wound care market due to the presence of developing economies like India and China and large unmet needs. Indian healthcare sector is one of the fastest growing at an expected CAGR of 22.87 % during 2015 to 2020 and is anticipated to reach USD 280 billion by 2020. Favorable government policies like the National Health Insurance and growth in healthcare expenditure is expected to boost the market.
The Middle East & Africa is expected to generate a moderate growth due the presence of poor economies. The Gulf economies of Saudi Arabia, UAE, Kuwait, and Qatar dominate the Middle East and Africa region owing to well-developed healthcare sector and large healthcare expenditure.
Dominant players:
Some of the dominant players in the market are Ethicon, Inc. (U.S.), Braun Melsungen AG (Europe), Kinetic Concept, Inc. (U.S.), 3M (U.S.), Baxter (U.S.), Smith & Nephew (U.S.), ConvaTec (Europe), and others.

Friday, 13 December 2019

Contact Lenses Market will register a CAGR of almost 5.7% by 2023

Market Synopsis:
Rising prevalence of eye disorders has led to an increase in demand for contact lenses, especially in the urban areas. A study conducted recently by Market Research Future has asserted that the Global Contact Lenses Market is expected to mark a CAGR of 5.70% across the projection period 2018 to 2023. The assessment further highlights that the global market’s valuation is anticipated to grow from USD 7.9 Billion in 2017 to USD 11 Bn by 2023.
Increasing disposable income has led to a shift in preferences to contact lenses over spectacles. This, in turn, is projected to proliferate the contact lenses market over the next couple of years. Also, technological innovations for offering more comfort to the users is expected to boost the expansion of the market in the years to come. However, on the flip side, some contact lenses can’t be wearing for a long period as it causes discomfort. This, in turn, is poised to undermine the proliferation of the contact lenses market in the forthcoming years.
Competitive Dashboard:
The key players participating in the global Contact lenses market profiled in this MRFR report for a detailed share analysis are Johnson & Johnson, CooperVision, Novartis, and Bausch+Lomb. Other market players studied in the report are Oculus Private Limited, Bescon Co. Ltd., St. Shine Optical Co. Ltd, Neovision Co. Ltd., Hoya Corporation, CAMAC Optical Corp., Seed Co. Ltd., Menicon Co. Ltd., and Clearlab SG PTE Ltd.
Market Segmentation:
By type, the global contact lenses market is segmented into therapeutic lenses, corrective lenses, and cosmetic & lifestyle oriented lenses. Among these, the corrective lenses segment is, at present, leading the growth of the market. It is anticipated to retain its prominent position over the next few years, reflecting a relatively higher CAGR of 5.22% during the assessment period. Factors such as the rising burden of eye disorders, rising geriatric population, increasing prevalence of geriatric eye diseases, etc. are expected to drive the expansion of the segment in the foreseeable future.
By material, the contact lenses market has been segmented into methacrylate hydrogel soft contact lens, gas-permeable contact lens, silicone hydrogel soft contact lens, and others. The silicone hydrogel soft contact lens segment is projected to account for over 60% of the market share by the end of the review period. The growth can be accredited to factors such as longer life span and high adoption for correcting astigmatism.
On the basis of design, the global contact lenses market has been segmented into toric lens, spherical lens, multi-focus lens, and others. Among these, the spherical lens segment is expected to account for more than 50% of the market share in the forthcoming years. The development of the segment is likely to be led by increasing cases of myopia and other refractive vision errors. In addition, the multifocal segment is prognosticated to expand at a comparatively higher CAGR across the projection period.
Regional Analysis:
The global contact lenses market, for a detailed geographical assessment, has been segmented into five major geographies - Europe, Asia Pacific, Latin America, North America, and the Middle East & Africa (MEA). Americas is leading the growth of the market currently and is anticipated to maintain its stand at the forefront position through the review period. Increasing demand for cosmetic lenses is a major factor expected to influence the expansion of the contact lenses market in the region in the upcoming years. In addition, the increasing burden of eye-related diseases is anticipated to expedite market growth over 2023. In the region., Meanwhile, Asia Pacific is poised to register the highest CAGR of 6.2% over the forecast period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312

Thursday, 12 December 2019

Creatinine test Market : Latest Innovations, Drivers, Restraints, Challenges and Key Events in the industry by 2023

The global creatinine test market size is set to balloon till 2023 owing to rising incidence of chronic kidney disease (CKD) and technological advances witnessed in various diagnostic test kits. Market Research Future (MRFR)’s latest study reveals that the market is predicted to grow at a 5.8% CAGR during the forecast period (2018–2023). Government initiatives undertaken to create awareness of CKD among patients is expected to positively impact the market. Product launches by new and existing players to expedite the speed and accuracy of these tests can offer new growth opportunities for the market.


Increased emphasis on quality healthcare is anticipated to increase the healthcare budget of various nations, which in turn could bolster market demand for creatinine tests. According to a report by the National Center for Chronic Disease and Prevention, nearly 30 million U.S. residents were afflicted with CKD in 2017. This disease was more commonly seen in women more than men. Technologically advanced creatinine tests can help in lowering these numbers considerably. Advances in point-of-care diagnostics facilitated by automated analyzers, increasing diabetic populace, and presence of various public and private healthcare organizations providing support for CKD management can open up new avenues for the market.
Global Market for Creatinine Tests – Segmental Analysis
MRFR’s report offers a detailed segmental analysis of the market based on test type, product type, application, end-user, and region. By type, the market has been segmented into blood test, urine test, and creatinine clearance test. The blood test segment accounted for a large market share owing to preference of blood tests to measure creatinine levels in the Americas. It is expected to be lucrative for the market over the forecast period.
By product type, the market is segmented into consumables and instruments. Consumables are further segmented into cartridges, urine test strips, and others. Similarly, instruments are further segmented into clinical analyzers and others. Clinical analyzers are segmented into benchtop and handheld. The consumables segment is projected to register a 5.71% CAGR during the forecast period, as tools such as urine test strips can provide an accurate assessment of a patient’s urine level.
Major market applications include renal failure, kidney cancer, glomerulonephritis, urinary tract obstruction, and others. The urinary tract obstruction application segment is touted to capture a lion’s share of the creatinine test market by the end of the forecast period owing to the urinary tract being the most common area for blockage. The renal failure segment is expected to grow at a 6.26% CAGR over the forecast period.
End-users covered in the report include research institutes, diagnostic centers, hospitals & clinics, and others. The hospitals and clinics segment is expected to contribute to the market owing to rise in healthcare budgets of various nations.
Regional Outlook
The creatinine test market, on the basis of region, is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The Americas region accounted for a large share of the market in 2017. It will continue to dominate the market due to presence of sophisticated healthcare infrastructure, adoption of latest diagnostic tests, and incidence of CKD. Presence of various leaders of the healthcare industry coupled with a massive healthcare budget is expected to facilitate market growth. Favorable reimbursement policies can also influence patients in taking these tests to catch kidney related disorders at a preventive stage.
APAC and Europe collectively accounted for 51% market share. The APAC creatinine test market is driven by the large patient pool, rapidly improving healthcare infrastructure, and adoption of latest customer-centric healthcare models.
Global Market for Creatinine Test – Competitive Dashboard
Some of the key players profiled in the market report include Abbott, URIT Medical, Nova Biomedical, Siemens AG, ARKRAY, Inc., The Danaher Corporation, F. Hoffmann-La Roche AG, ACON Laboratories, Inc., Thermo Fisher Scientific, Inc., Quest Diagnostics, Abcam plc, OPTI Medical Systems, and others. Acquisitions, collaborations, and launch of new products are strategies employed by these players to acquire a larger market share. Approvals of new creatinine tests by respective regulatory agencies of various nations are expected to propel the market to new heights.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312

Autism Disorder and Treatment Market Size, Regional Outlook, Competitive Strategies and Forecasts to 2023

Autism Disorder and Treatment Market – Overview
The neurological and developmental effects of autism disorder are the core factors promoting the expansion of treatment and diagnostic options for autism. Market reports linked to the healthcare industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios. The market is reportedly poised to achieve a CAGR of 4.37% approximately in the duration of the forecast period.
Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/1605
Autism Disorder and Treatment Market Segmentation
The global autism disorder and treatment market segmentation encompasses drugs, type, and treatment type. MRFR’s research on the market highlights many facets of the market in-depth.
Based on drugs, this market has been segmented into anti-convulsant drugs, anti-psychotic drugs, selective serotonin reuptake inhibitors (SSRIs), and stimulants. The antipsychotic drugs segment has been sub-segmented into Abilify (aripiprazole) and risperidone. The antipsychotic drugs segment has the maximum market coverage and is expected to grow at 3.95% CAGR during the forecast period.
By type, the market includes Asperger syndrome, pervasive developmental disorder, and others. During the forecast period, the pervasive developmental disorder is expected to grow at 4.73% CAGR, as it is the largest market segment.
Regarding treatment type, the market has been segmented into the applied behavioral analysis (ABA), chelation therapy, hyperbaric oxygen therapy, oxytocin therapy, and others. ABA is the largest and market segment, and during the forecast period, it is expected to grow at 4.82% CAGR.
Autism Disorder and Treatment Market Regional Segmentation
A geographical outlining of the global Autism Disorder and Treatment Market covers the Americas (North America & South America), Europe, APAC (Asia Pacific), and the Middle East & Africa (MEA).
The Americas region commands the maximum market share in the global market, followed by Europe. The presence of major market players, availability of advanced medical facilities, and technological advancement make North America a bigger market compared to South America. The market in North America is growing due to the approval, and it expects the launch of the atypical anti-psychotic such as Latuda and Namenda, with their high sales in the USA. Many autism cases have been detected in North America. After the USA, Canada generates maximum sales as well as revenue with regards to autism treatment and drugs.
Europe is the second-largest regional market as after North America; maximum major market players are based in Europe. The countries that can become important markets during the forecast period are France, Germany, Italy, Spain, and the UK. Research on the remaining countries in Western Europe featured in this report estimate the strong addition to market revenue from various other countries in this region, with some sizable market revenue from Eastern Europe.
During the forecast period, the market in the Asia Pacific region can be the fastest growing regional market. In this region, the factors contributing to the market growth include the expansion of diagnostic criteria, increasing prevalence of ASD, more awareness, better diagnostic tools, and improved reporting. The countries that can be crucial markets in this region are Australia, China, India, Japan, and South Korea.
During the forecast period, the market in the MEA region can grow steadily due to slow progress in the improvement of healthcare infrastructure. The countries that can be decent markets in this region are Kuwait, Oman, Saudi Arabia, Qatar, and the UAE.
Autism Disorder and Treatment Market Analyzed by Top Key Players
Big players in the global autism disorder and treatment market are Allergan (Ireland), Bristol-Myers Squibb (USA), Consern Pharma Private Limited (India), Coronis Partners Ltd. (Israel), Curemark LLC (USA), Eli Lilly & Company (USA), Heptares Therapeutics Limited (UK), Intra-Cellular Therapies Inc. (USA), Johnson & Johnson Services Inc. (USA), Merck & CO Inc. (USA), Novartis AG (Switzerland), Otsuka Holdings Co. Ltd. (Japan), Pfizer Inc. (USA), Saniona AB (Denmark), and Teva Pharmaceutical Industries Ltd. (Israel).
Latest Industry News
  • National Institute of Mental Health has awarded grant worth USD 3.3 Mn to Zylka Lab. The grant was approved based on a study and would be used for a better understanding of a genetic mutation in UBE3A that contributes to certain characteristics of autism. 18 SEP 2019

Medical Tourism Market: Worldwide Insight & Projection, Growth and Opportunities 2019-2023

 Market Insights
Increasing costs of treatments for chronic diseases and other kinds of treatment have been highly encouraging of medical tourism. It has been a common practice in an effort to procure good treatment at lower costs. Developing economies around the world offer high-quality medical treatments which attract patients from other parts of the world. Market Research Future has published its newest report on the global medical tourism market which reveals an expected and promising CAGR of  21.4% during the forecast period from 2017 to 2023. The market was found to be valued at USD 70,836.9 Mn at the start of the forecast period and is likely to grow to reach an impressive USD 226,762.7 Mn by the end of 2023.
The global medical tourism market is expected to exhibit a strong 21.4% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global medical tourism market is mainly driven by the growing awareness about the availability of healthcare processes at low prices in the developing world. The report presents a detailed breakdown of the global medical tourism market’s key drivers and restraints, allied with an analysis of the economic background of the market. Microeconomic and macroeconomic factors having a lasting impact on the global medical tourism market are studied in detail in the report. The leading players operating in the global medical tourism market are also studied in detail in the report.
Receive Free Sample of this Report @ https://www.marketresearchfuture.com/sample_request/1975
Medical Tourism Market- Competitive Analysis:
Leading players in the global Medical Tourism Market include Asklepios Kliniken Verwaltungsgesellschaft mbH, Clemenceau Medical Center, Fortis Healthcare, Bangkok Hospital, Shouldice Hospital, Anadolu Medical Center, Prince Court Medical Centre, Gleneagles Global Hospitals Group, Schön-Kliniken, Samitivej PCL, CHRISTUS MUGUERZA, and Bumrungrad International Hospital.
In November 2019, Bangkok Dusit Medical Services announced a collaboration with Really Really Cool, a travel experience company, to sell medical tourism schemes to Chinese customers.
Medical Tourism Market Segmentation:
Market Segmentation
The global medical tourism market is segmented on the basis of type. This is divided into neurology/neurosurgery treatments, orthopedic/spine treatments, fertility/IVF treatments, cosmetic treatments, cardiovascular/cardiology treatments, oncology/cancer treatments, and dental treatments. Among these, The cosmetic treatments market is the most lucrative segment with a high demand for facial rejuvenation and breast reconstruction treatments. The cost-efficient prices at medical tourism destinations for cosmetic procedures drive the segment's growth.
Medical Tourism Market- Regional Analysis:
Asia Pacific holds the largest share in the global medical tourism market and is likely to remain the leading revenue generator over the forecast period. Asia Pacific holds a dominant 43.7% share in the global medical tourism market and is expected to grow at a CAGR of 22% over the forecast period from 2017 to 2023. South Korea, in particular, has emerged as a leading exponent of cosmetic surgeries, which has driven the share of Asia Pacific in the global medical tourism market.
Eastern and Central European countries are also expected to emerge as promising destinations for medical tourism over the forecast period.
Browse the market data and information spread across 90 pages with 49 data tables and 18 figures of the report “Medical Tourism Market Report - Forecast 2019-2023” in-depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/medical-tourism-market-1975

Monday, 9 December 2019

Medical Marijuana Market is growing at a CAGR of + 34.0% 2023 with key players like Canopy Growth Corporation, Cannabis Sativa, GW Pharmaceuticals Plc, Emerald Health Therapeutics and Others

The global Medical Marijuana Market is already hitting milestones one after another, mainly due to the medical acceptance of Cannabidiol (CBD) and tetrahydrocannabinol (THC), the main psychoactive parts of marijuana. The medical marijuana industry has already demonstrated a rapid surge in sales, combined recreational and medical. Over the past couple of years, several countries have introduced marijuana Medicalization bills, laying out a plan for the medical marijuana dispensaries nationwide, beginning to sell the cannabis-infused drugs.
Moreover, the medicalization of marijuana-infused edibles and other extracts is increasing revenues in the medicinal marijuana businesses, dramatically. Market Research Future (MRFR), asserts that the global medical marijuana market is estimated to garner USD 54,677.1 MN by 2023. In its recent market statistics, MRFR also confirms that the market would register a massive 34% CAGR throughout the forecast period (2018-2023).
Until a couple of years ago, the marijuana industry was operating mainly in the black market. However, the tables have turned dramatically with the emergence of medical applications, increasing the size of the medical marijuana market. The flourishing medical marijuana industry is a conglomerate of science and technology, which is why medical marijuana is arguably the fastest growing industry globally.
On the other hand, the demand-supply gap, logistical challenges, and a smattering of medical violations are some of the factors projected to obstruct the growth of the market. Nevertheless, the augmenting market demand would support the marijuana industry growth throughout the forecast period.

Global Medical Marijuana Market – Segmentations
MRFR has segmented the market into four dynamics to widen the scope of understanding,

By Product Type                : Solids, Dissolvable/Powders, Oil, Ointments & Creams, and others.
By Application                   : Alzheimer’s Disease, Cancer, Schizophrenia, Multiple Sclerosis, and others.
By Distribution Channel  : Retail & Pharmacy Stores, Online Platforms, and others.
By Regions                          : Europe, North America, Asia Pacific, and the Rest-of-the-World.
  
Global Medical Marijuana Market - Regional Analysis
North America is a hub for marijuana-based medicine companies and hence accounts for the largest share in the global medical marijuana market. The huge success of the market also attributes to the largest production and consumption of marijuana for medicinal purposes. Moreover, medical acceptance of cannabis in various North American countries drives the growth of the regional market, witnessing the increasing pharmaceutical applications. The market is projected to register over 34.0% CAGR during the forecast period. 
The medical marijuana market takes the second position, holding 5.5the market share, globally. In Europe, annually, huge numbers of advancements take place in the field of medical science, biotechnology, medicines/ pharma, and technology. Also, the region witnesses increasing the prevalence of Alzheimer's disease, cancer, and others, which in turn drive the growth of the market.
The Asia Pacific region has emerged as a promising market for medical marijuana. Factors such as the increasing consumption in countries such as Turkey, Australia, and the Philippines foster regional market growth. Furthermore, extensive researches on the marijuana spices to bring out value-added products from cannabis strains has been contributing to the growth of the APAC medical marijuana market.

Global Medical Marijuana Market - Competitive Analysis
Highly competitive, the medical marijuana market appears to be well-established and fragmented with the presence of several large and small-scale players. To gain a significantly larger share in the market, players incorporate strategic initiatives such as mergers & acquisitions, collaborations, and expansion. They invest heavily in R&D and clinical trials to develop medical-grade marijuana.
Major Players:
Players leading the global medical marijuana market include Cannabis Sativa Inc (US), Canopy Growth Corporation (US), GW Pharmaceuticals Plc (US), Tilray (Nanaimo, BC), Emerald Health Therapeutics Inc. (Canada), Aphria (Canada), Cara Therapeutics (US), Pfizer Inc. (US), CanniMed Ltd (Canada), Medical Marijuana Inc (US), MediPharm Labs (US), and GBSciences Inc. (US), among others. 
Industry/ Innovations/ Related News 
November 28, 2019 ---- Terrace Global Inc.(Canada), a multi-national operator for cannabis assets, announced the completion of its acquisition of Oransur, a high CBD hemp cultivation business in South America. Terrace Global is led by experienced cannabis entrepreneurs focused on the development and acquisition of international cannabis assets.
Oransur is a licensed hemp producer holding up to 150 acres in Uruguay, where the cultivation of hemp is allowed with up to 1% THC contents and without restrictions on other cannabinoids, such as CBD and CBG.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312

Protein Engineering Market is driven by the increasing demand for new technologies


Market Research Future has recently added another market study to its extensive research portfolio, titled “Protein Engineering Market Research Report - Forecast to 2024”. The report offers intelligent insights and uses thorough examination of market factors to gauge market size and development.
Global Protein Engineering Market is expected to grow at a CAGR of approximately 6.2% during the forecast period 2017–2023.
Key Players:
Agilent Technologies (U.S.), AB-Sciex (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).


Market Scenario:
Proteins, the building blocks of the body, are large biomolecules made up of amino acids. They perform various functions such as DNA replication, catalyzing metabolic reactions, transporting molecules from one location to another, and responding to stimuli. Furthermore, proteins also have a wide range of applications in the diagnosis of disease and treatment development. Protein engineering involves designing and constructing new proteins by modifying amino acid sequences to produce enzymes and desired properties and the synthesis of proteins with a particular structure. This technology helps us to understand the basics of how enzymes function and have evolved, and it is the key method of improving enzyme properties for applications in pharmaceuticals, green chemistry, and biofuels.
The major objective of protein engineering is to produce biological compounds which include a synthetic peptide, storage protein, and synthetic drugs which will be superior to a normal one and create an enzyme which is superior in its properties to produce high-value chemicals in large quantities.
The global protein engineering market is driven by the increasing demand for new technologies having their application in healthcare and by the growth in research and development activities for improving health outcomes using novel technologies. Furthermore, the emergence of trends in protein identification and tracking and the increasing use of protein studies in research activities drive the growth of this market. However, there are various factors that may hinder the growth of the market such as expensive instruments used in protein engineering that require huge maintenance and lack of trained personnel.

Segmentation:
The Global Protein Engineering Market is segmented to the basis of type, method, application, and end-users.
On the basis of type, the market is segmented into instrument, reagents, and services and software.
On the basis of method, the market is segmented into rational protein design and directed evolution.
On the basis of application, the market is segmented into food and detergent industries, environment applications, medical applications, biopolymer production, and nanobiotechnology.
On the basis of end-user, the market is segmented into academic research institutes, pharmaceuticals and biotechnology companies, and contract engineering organizations.

Regional Analysis:
Globally, protein engineering market consists of four regions, namely, Americas, Europe, Asia Pacific, and the Middle East and Africa. North America is the largest market owing to the concentration of major market players and increase in a number of biotechnology and pharmaceutical companies. The U.S. is the largest market in North America followed by Canada. In the U.S., extensive protein engineering technologies and methods and availability of technologically-advanced devices and instruments for research also drive the growth of the market.
Europe is the second largest market for protein engineering which is majorly driven by the increasing demand for protein engineering methods and technologies and the overall growth of research and development sector in major countries such as Germany, the U.K., and France. Furthermore, the growth in funding for protein engineering and emphasis on drug discovery are other factors expected to drive the growth of the market during the review period.
Asia Pacific shows the fastest growth which is driven by the rising prevalence of lifestyle diseases such as heart diseases, diabetes, obesity, and others and need for new technologies with their application in healthcare.
The Middle East and Africa shows a steady but positive growth with an increase in the demand for new drugs and devices for diagnosis and the treatment of diseases and improvement in healthcare infrastructure.


Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Type Ology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
… Continued!

Hottest Trending Report